A subset of SLE patients has serologically detectable autoantibodies to the ribosomal P proteins (anti-P). We reported the discovery of covert anti-P antibodies and their masking IgG-inhibitory antibodies in the sera of healthy adults. The aim of this study was to determine if these IgG-inhibitory antibodies are anti-idiotypic antibodies (anti-Ids). IgG and IgG-depleted fractions of plasma from two healthy adults were assayed for inhibition of anti-P F(ab')2 binding to the ribosomal P proteins in immunoblot. Anti-P antibody activity was completely inhibited by plasma IgG, whereas there was no inhibition by IgG-depleted plasma. IgG-inhibitory antibodies recognized a cross-reactive epitope among anti-P from different SLE patients. Plasma IgG from one healthy adult was depleted of pepsin agglutinators and generic anti-F(ab')2 antibodies by adsorption with an affinity column prepared with normal IgG F(ab')2. Unretained IgG bound exclusively to anti-P F(ab')2 in ELISA. Using four affinity columns, we isolated IgG anti-Ids to anti-P antibodies from four healthy adults. These purified anti-Ids bound to anti-P F(ab')2 from a healthy adult and SLE patients. They did not bind to F(ab')2 fragments prepared from normal IgG or anti-dsDNA. Ribosomal antigens blocked this anti-Id-Id interaction. Purified anti-Ids inhibited the binding of anti-P F(ab')2 from patients to ribosomal P proteins. SLE patients without overt anti-P antibodies also possessed IgG anti-Ids to anti-P antibodies. We conclude that IgG-inhibitory antibodies are anti-Ids to anti-P antibodies, and are directed to public idiotopes on anti-P antibodies. These anti-Ids may be part of an Id network that regulates anti-P antibody expression, and perhaps pathogenicity.
Z J Pan, C J Anderson, H A Stafford
Title and authors | Publication | Year |
---|---|---|
Immunomodulatory potential of anti-idiotypic antibodies for the treatment of autoimmune diseases
SY Pan, YC Chia, HR Yee, AY Cheng, CE Anjum, Y Kenisi, MK Chan, MB Wong |
Future Science OA | 2020 |
Immunogenic properties of immunoglobulin superfamily members within complex biological networks
J Odales, JG Valle, F Martínez-Cortés, K Manoutcharian |
Cellular Immunology | 2020 |
Autoantibodies in SLE: Specificities, Isotypes and Receptors
B Dema, N Charles |
Antibodies | 2016 |
Anti-ribosomal-phosphoprotein autoantibodies penetrate to neuronal cells via neuronal growth associated protein, affecting neuronal cells in vitro
S Kivity, Y Shoenfeld, MT Arango, DJ Cahill, SL OKane, M Zusev, I Slutsky, M Harel-Meir, J Chapman, T Matthias, M Blank |
Rheumatology | 2016 |
Anti-ribosomal-P antibodies in lupus nephritis, neuropsychiatric lupus, lupus hepatitis, and Chagas’ disease: promising yet limited in clinical utility
M Abraham, CT Derk |
Rheumatology International | 2014 |
Anti-Idiotypic Antibody Specific to GAD65 Autoantibody Prevents Type 1 Diabetes in the NOD Mouse
X Wang, A Zhang, Y Liu, S Chen, Z Feng, W Shang, M Maziarz, J Radtke, CS Hampe |
PloS one | 2012 |
Protective role of anti-idiotypic antibodies in autoimmunity – Lessons for type 1 diabetes
CS Hampe |
Autoimmunity | 2012 |
Anti-Idiotypic Antibody Specific to GAD65 Autoantibody Prevents Type 1 Diabetes in the NOD Mouse
X Wang, A Zhang, Y Liu, S Chen, Z Feng, W Shang, M Maziarz, J Radtke, CS Hampe, IR Cohen |
PloS one | 2012 |
Maternal Fetal Transmission of Human Viruses and their Influence on Tumorigenesis
G Berencsi |
2012 | |
Reactivity against complementary proteinase-3 is not increased in patients with PR3-ANCA-associated vasculitis
H Tadema, CG Kallenberg, CA Stegeman, P Heeringa |
PloS one | 2011 |
The immunogenicity of humanized and fully human antibodies: Residual immunogenicity resides in the CDR regions
FA Harding, MM Stickler, J Razo, R DuBridge |
mAbs | 2010 |
Autoimmunity: increasing suspects in the CD4+ T cell lineup
MT Palmer, CT Weaver |
Nature Immunology | 2009 |
Antiphospholipid antibodies: paradigm in transition
LL Horstman, W Jy, CJ Bidot, YS Ahn, RE Kelley, R Zivadinov, AH Maghzi, M Etemadifar, SA Mousavi, A Minagar |
Journal of Neuroinflammation | 2009 |
Comparison of three assays for the detection of GAD65Ab-specific anti-idiotypic antibodies
S Oak, J Radtke, M Landin-Olsson, C Törn, A Lernmark, CS Hampe |
Journal of Immunological Methods | 2009 |
Evaluation of anti-ribosomal P protein immunoassay in Japanese patients with connective tissue diseases: comparison with an indirect immunofluorescence assay
Y Muro, K Sugiura, Y Morita, Y Tomita |
Scandinavian Journal of Rheumatology | 2009 |
Naturally occurring auto-antibodies in homeostasis and disease
HU Lutz, CJ Binder, S Kaveri |
Trends in Immunology | 2009 |
The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes
S Oak, LK Gilliam, M Landin-Olsson, C Törn, I Kockum, CR Pennington, MJ Rowley, MR Christie, JP Banga, CS Hampe |
Proceedings of the National Academy of Sciences | 2008 |
Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis
S Matus, PV Burgos, M Bravo-Zehnder, R Kraft, OH Porras, P Farías, LF Barros, F Torrealba, L Massardo, S Jacobelli, A González |
Journal of Experimental Medicine | 2007 |
The therapeutic potential of targeting anti-Ribosomal-P antibody in treating SLE patients with depression
M Blank, I Beinglass, Y Shoenfeld |
Expert Opinion on Biological Therapy | 2007 |
The Autoimmune Diseases
I Kang, J Craft |
The Autoimmune Diseases | 2006 |
Production and characterization of a human monoclonal anti-idiotype to anti-ribosomal P antibodies
W Zhang, M Reichlin |
Clinical Immunology | 2005 |
BLyS antagonists and peptide tolerance induction
JT Merrill |
Lupus | 2005 |
Autoantibody-mediated Inhibition of Pancreatic Cancer Cell Growth in an Athymic (Nude) Mouse Model
J Gardner-Thorpe, H Ito, SW Ashley, EE Whang |
Pancreas | 2003 |
Antiidiotypic antibodies neutralize autoantibodies that inhibit cholinergic neurotransmission
D Cavill, SA Waterman, TP Gordon |
Arthritis & Rheumatism | 2003 |
Lupus-specific kidney deposits of HSP90 are associated with altered IgG idiotypic interactions of anti-HSP90 autoantibodies
A Kenderov, V Minkova, D Mihailova, N Giltiay, S Kyurkchiev, I Kehayov, M Kazatchkine, S Kaveri, A Pashov |
Clinical & Experimental Immunology | 2002 |
Possible role of antiidiotypes in the loss of anti-topoisomerase I antibodies: Comment on the article by Kuwana et al
HA Stafford, ZJ Pan, CJ Anderson |
Arthritis & Rheumatism | 2001 |
A Murine Monoclonal Anti-idiotype to Anti-ribosomal P Antibodies: Production, Characterization, and Use in Systemic Lupus Erythematosus
ZJ Pan, CJ Anderson, HA Stafford |
Clinical Immunology | 2001 |
The Leishmania infantum acidic ribosomal protein LiP2a induces a prominent humoral response in vivo and stimulates cell proliferation in vitro and interferon-gamma (IFN-gamma) production by murine splenocytes
M Soto, C Alonso, JM Requena |
Clinical & Experimental Immunology | 2000 |
Anti-idiotypic antibodies to anti-PDC-E2 in primary biliary cirrhosis and normal subjects
Q Chen, MJ Rowley, IR Mackay |
Hepatology | 1999 |